ARTICLES BY THIS AUTHOR
- 11/6/2019
RedHill Biopharma gets FDA green light for Talicia
RedHill's Talicia is the first and only FDA approved rifabutin-based H. pylori infection therapy. - 11/1/2019
President Trump to nominate oncologist Stephen Hahn as FDA commissioner
President Trump will nominate Stephen Hahn, chief medical executive at The University of Texas MD Anderson Cancer Center, as FDA commissioner. - 11/1/2019
Hy-Vee, customers to honor veterans, active-duty military members, and families
Hy-Vee will match customer donations up to $100,000, during its seventh annual Hy-Vee Homefront Round Up this month. - 10/31/2019
Alembic launches generic Tricor
Alembic is launching generic Tricor tablets in two dosage strengths. - 10/31/2019
NACDS restructures, shifts staff roles to empower its issue campaigns
NACDS' federal government affairs, state government affairs, and public policy now will operate as dedicated and distinct, yet highly collaborative, functions. - 10/31/2019
Hy-Vee to provide free A1C screenings in November
Free hemoglobin A1C screenings will be offered on a first-come, first-served basis at the Hy-Vee Healthy You Mobiles in 160 Hy-Vee store parking lots. - 10/31/2019
SunGen gets FDA nod for lidocaine ointment
Lidocaine has a market value of about $60 million. - 10/30/2019
Aurobindo’s generic Lodosyn gets FDA OK
Carbidopa tablets had a market value of roughly $7.7 million for the 12 months ending August 2019, according to IQVIA. - 10/30/2019
NCPA names new president, approves changes on pharmacy payment model
NCPA delegates adopted several resolutions, including one urging policymakers to support reforms compensating pharmacists for the true cost of dispensing medicines. - 10/30/2019
Biogen, Alkermes get FDA OK for Vumerity
Biogen's and Alkermes' Vumerity is a new oral treatment option for relapsing forms of multiple sclerosis.